SRT-015: Novel ASK1 Inhibitor for the Treatment of NASH

Poster presentation at Keystone Symposia

Integrated Pathways of Disease in NASH and NAFLD, Jan 2019

Seal Rock Therapeutics - 500 Yale Ave N, Seattle, WA 98109, USA - info@sealrocktx.com -786.453.0593